As Rare Disease day 2020 approaches, we take a look at the biggest challenges facing orphan drug developers and ask whether the future is bright or bleak for these difficult conditions.
Leela Barham says that there’s a communication problem when it comes to one of the most important and basic statistics about medicines in the UK: how much the UK spends on them.
